By using the stock compare feature, the efficiency of stock selection is greatly improved. I can select multiple stocks of the same industry at once and observe the fundamentals of multiple stocks at once, saving a lot of time. When you are unsure of how to choose, all you need to do is compare several similar stocks together to make the selection easier.
By observing the image below, I easily discovered $Tesla (TSLA.US)$Tesla's fundamentals (earnings per share, price-earnings ratio, earnings per share, price-to-book ratio, etc.) are the best among other companies in the same industry.
My another method below
When I have limited funds and need to choose stocks in different industries, I can also compare several stocks together and select the one that is more likely to be profitable.
How does Warren Buffett choose stocks? Buffett has said on multiple occasions that if he could only choose one indicator to measure a company, he would definitely choose ROE.
By looking at the following picture, if I have to choose one of the three stocks, I would prioritize selecting $Floor & Decor (FND.US)$ 。
It's easier to compare and choose several stocks together for comparison.

BofA Securities chooses 11 stocks, one per S&P 500 sector, for 2022, with 23% implied upside on average based on price targets.
These stocks are mostly neglected by active funds and benefit more from inflation, higher GDP, higher interest rates, higher oil prices and wage growth than an equal-weighted 11 sector portfolio, all of which we expect will occur in 2022."
--- strategist Savita Subramanian and team write in a note.
$Disney (DIS.US)$ $BorgWarner (BWA.US)$ $Mondelez International (MDLZ.US)$ $Exxon Mobil (XOM.US)$ $Wells Fargo & Co (WFC.US)$ $CVS Health (CVS.US)$ $Eaton (ETN.US)$ $F5 Inc (FFIV.US)$ $Eastman Chemical (EMN.US)$ $Welltower Inc (WELL.US)$

We are in a bifurcated market where there are opportunities in either long or short direction since Nov.
Many growth stocks like $Sea (SE.US)$, $Twilio (TWLO.US)$, $Unity Software (U.US)$, $CrowdStrike (CRWD.US)$ $Affirm Holdings (AFRM.US)$ $Fiverr International (FVRR.US)$ $Roku Inc (ROKU.US)$ $MercadoLibre (MELI.US)$ $DocuSign (DOCU.US)$ $PayPal (PYPL.US)$ are deeply oversold (30-60%).
Or as per Cathie Wood, they are in deep value zone.
Some of them showed relative strength against the $S&P 500 Index (.SPX.US)$ and near the support. There are some entry setups with decent reward to risk.
Possible to ride the overdued short term up swing after oversold with the current or aka the coming Santa Claus rally.

$CapLand IntCom T (C38U.SG)$ Buy it to collect food dividends... Look at the shopping malls surrounding the Singapore MRT. They are all C38U locations... Absolute potential+strength stocks.

$CapLand Ascendas REIT (A17U.SG)$
ok

$Affirm Holdings (AFRM.US)$ Jon Najarian was on World Wide Exchange this a.m. at 5 a.m. He reminded there will be more volatility today for Quad witching expiration. He said that the selling may continue to accelerate and that many people in the high multiple high flyers (he only mentioned "like $CrowdStrike (CRWD.US)$ and $Snowflake (SNOW.US)$ ") who had hoped that they may not have to sell will be looking to book losses now B4 EOY but then they can't buy back for 30 days until after January. So he said that makes these stocks very attractive in January. That sounds like there may be more selling and it isn't over. A SA article just posted yesterday said it is still too expensive even after yesterday's drop and recommended waiting for a lower price. Is that possible?

$FRASERS CENTREPOINT TRUST (J69U.SG)$ eating places in its malls mostly crowded . good 👍

$Biofrontera (BFRI.US)$ - Biofrontera AG Enrolls First Patient To Phase IIb Clinical Study Evaluating Ameluz / BF-RhodoLED For Acne. stock has support at $5.50
$QuantumScape (QS.US)$ - stock is near the support area of  $22. If held we can see a reversal to $25 plus or more.
$Longeveron (LGVN.US)$ - stock in consolidation mode. On watch for a break of $20 to keep moving higher.
$Lucid Group (LCID.US)$ - stock bouncing off $35 support as expected. Stock looking bullish above $40
$Galera Therapeutics (GRTX.US)$ - Galera Announces Primary Endpoint Met Statistical Significance In Corrected Topline Efficacy Data Of Phase 3 ROMAN Trial Of Avasopasem. Also Hearing BTIG Upgrades To Buy, Sets $15 Price Target